Australia’s expedited plan to start dishing out COVID jabs in mid-late February will call for NASA-like logistical organisation. And ideally, no more clusters of infections to distract frontline workers.
I am a physician, and I just got my first shot of the Pfizer COVID-19 vaccine.
William Petri
With vaccines forthcoming for most Americans, many groups, including expectant mothers, are wondering if the vaccine is safe for them and their babies. A physician-scientist explains.
The French government will not accept any passengers arriving from the U.K. amid fears over the new mutant coronavirus strain.
Steve Parsons/PA Images via Getty Images
A new strain of the SARS-CoV-2 virus that causes COVID-19 appears to be spreading fast in the UK. This probably isn’t a big problem, but the data isn’t in yet.
Sandra Lindsay, left, a nurse at Long Island Jewish Medical Center, is inoculated with the COVID-19 vaccine by Dr. Michelle Chester.
Mark Lennihan/Pool via Getty Images
A serious allergic reaction was reported in a health care worker in Alaska after she received the COVID-19 vaccine. Does this mean that people with allergies need to be concerned? An expert answers.
A dose of the Pfizer vaccine being prepared to be given to a health worker in California, USA.
EPA-EFE
Experts from across The Conversation assess the work that’s helped us reach vaccine roll-out, how this could play out, and the risk of vaccine hesitancy.
The number one scientific breakthrough for 2020: multiple vaccines to prevent COVID-19.
Philippe Raimbault/Photodisc via Getty Images
The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
Sandra Lindsay, a nurse at Long Island Jewish Medical Center, is given the COVID-19 vaccine – she is one of the first in the US to receive it.
EPA/Mark Lennihan
Here’s what we still need to find out before we can know when we’ll be able to return to our pre-coronavirus ways.
Workers prepare to ship the Pfizer COVID-19 vaccine from the company’s manufacturing plant in Kalamazoo, Michigan.
Morry Gash/Pool/AFP via Getty Images
As the coronavirus rages, a vaccine finally is available for certain groups of people and will soon be ready for other groups. But there are plenty of questions. A doctor answers five here.
We still need to know exactly what part of the immune response offers protection – and how strong it needs to be to remain protective.
The pharmaceutical industry opposes the suspension of intellectual property rights on COVID-19 vaccines and treatments, and no pharma companies have yet contributed to the COVID-19 Technology Access Pool.
(Shutterstock)
We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
Reports of two UK health workers having allergic reactions after receiving Pfizer’s COVID vaccine have led to safety warnings for others at risk of anaphylaxis.
A nurse at the Royal Free Hospital in London simulates the administration of the Pfizer vaccine on Dec. 4, 2020 to support staff training ahead of the rollout in the United Kingdom.
(Yui Mok/Pool Photo via AP)
If supplies of COVID-19 vaccine are initially limited, who should be vaccinated first? A mathematical model shows when and why it’s best to start with the young, and when older people should go first.
Parents also want to know about safety, side effects and if they’ll still have to wear masks.
FatCamera via Getty Images
Vaccine hesitancy is not new, but it has a new element: few people can remember the devastating impact of diseases such as smallpox and polio and it is hard to see the lives saved by vaccination.
It may be many months before COVID control measures can be eased.
A nurse prepares a shot for a clinical trial of a COVID-19 vaccine candidate developed by the National Institutes of Health and Moderna Inc., on July 27, 2020 in Binghamton, N.Y.
(AP Photo/Hans Pennink, File)
With COVID-19 vaccine announcements making headlines, non-scientists need to know what clinical trial results mean. Here are some key points to look for in vaccine trial reports.
Now there is a third possible vaccine for fighting the COVID-19 pandemic.
Jakub Porzycki/NurPhoto via Getty Images
There is now a third vaccine that prevents COVID-19 infections. It isn’t quite as effective as the other two vaccines but it has advantages that may make it the frontrunner.